An interventional study of Active tDCS and Cognitive Training in Fetal Alcohol Spectrum Disorders, sponsored by University of Minnesota. Recruiting at 1 site in United States. Open to participants aged 8 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-01-20.
Sponsored by University of Minnesota · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 37 studies in Fetal Alcohol Spectrum Disorders with a site in United States — 10 open to participants now, 11 under way, none of them phase 3. Fetal Alcohol Spectrum Disorders · United States.
Among the 37 studies in Fetal Alcohol Spectrum Disorders with a site in United States, this one is the 19th largest by planned enrollment of the 34 interventional ones that give a count, is one of 3 that started in 2022, is one of 22 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 26th registered.
65 studies on the registry are indexed under Fetal Alcohol Spectrum Disorders; 13 are open to participants now.
Browse Fetal Alcohol Spectrum Disorders studies →10 of the 37 studies in Fetal Alcohol Spectrum Disorders with a site in United States are open now. Recruiting first, the newest first:
University of Virginia · Sites in United States
Ages 18–44 · Women only · Healthy volunteers
University of Rochester · Sites in United States
Ages 18–25
Stanford University · Sites in United States
Ages 18–40 · Healthy volunteers
University of California, Los Angeles · Sites in United States
Ages 8–12
University of Rochester · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 12 Fetal Alcohol Spectrum Disorders studies recruiting now, 4 (33%) set no upper age limit and 8 (67%) stop at 75 or younger; 4 take children under 18; 5 take healthy volunteers.
This study: 8 Years to 17 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
37 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 8 · Phase 3 1
First in 2001; this study’s year is marked. 3 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 70 is close to the median of 74 across 57 interventional studies indexed under Fetal Alcohol Spectrum Disorders.
Median enrollment 85 across the 34 interventional studies, 751 across the 3 observational. Of the 26 that completed or were terminated, 10 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 37 has an industry lead sponsor. The 10 most frequent:
University of Minnesota is the lead sponsor of 1,219 studies on the registry; 199 are open to participants now.
Of its 136 completed or terminated interventional studies of FDA-regulated products, 95 (70%) have results posted.
University of Minnesota has 4 studies filed under Fetal Alcohol Spectrum Disorders — fewer than ten, so there is no comparison to draw.
6 of the studies in Fetal Alcohol Spectrum Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06847165University of California, Los AngelesTrigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure | 2026-12-29 |
| NCT06635746Stanford UniversityDose Escalation Study of Vinpocetine in Healthy Volunteers | 2026-12-31 |
| NCT06638463University of RochesterMy Health Coach App RCT | 2026-12-31 |
| NCT05960461University of RochesterFamilies Moving Forward (FMF) Connect Pro for Mental Health Providers | 2027-04-30 |
| NCT05456321University of MinnesotaCIFASD 5 tDCS and Cognitive Training | 2027-05-31 |
Add all 6 to your calendar (.ics) → With an account.
Among the 37 studies in Fetal Alcohol Spectrum Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 8 - 17 years) with prenatal alcohol exposure (PAE).
Prenatal alcohol exposure (PAE) has profound detrimental effects on brain development and, as a result, has permanent consequences for cognition, learning, and behavior. Individuals with Fetal Alcohol Spectrum Disorders (FASD) commonly have a range of neurocognitive impairments that directly lead to practical problems with learning, attention, working memory, task planning/execution, and decision making, among other areas of functioning. Despite the profound public health burden posed by FASD, there have been very few treatment studies in this population. This study will examine the effects of a cognitive remediation training augmented with transcranial direct current stimulation (tDCS) in children and adolescents with PAE. The study involves a baseline visit with cognitive testing, 5 sessions of tDCS (including the baseline visit) with active and sham arms, a 6th visit for cognitive testing.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
5 sessions of computerized executive functioning training - plus active tDCS (also 5 sessions).
Device: Active tDCS · Behavioral: Cognitive Training
5 sessions of computerized executive functioning training - plus sham tDCS (also 5 sessions).
Behavioral: Cognitive Training · Device: Sham tDCS
Active Transcranial Direct Current Stimulation (tDCS)
Computerized Cognitive Training
Sham Transcranial Direct Current Stimulation (tDCS)
Change in Continuous Performance Test performance
Change in Continuous Performance Test performance
Time frame: After each study visit (approx. bi-weekly) for the duration of the study (10 visits, approx. 5 weeks)
Change in Delis-Kaplan Executive Function System -Trail Making performance
Change in Delis-Kaplan Executive Function System - Trail Making performance
Time frame: Visit 1 and Visit 5 (approx. 3 weeks apart)
Change in Delis-Kaplan Executive Function System Color Word Interference performance
Change in Delis-Kaplan Executive Function System - Color Word Interference performance
Time frame: Visit 1 and Visit 5 (approx. 3 weeks apart)
Change in Wechsler Digit Span performance
Change in Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Digit Span performance
Time frame: Visit 1 and Visit 5 (approx. 3 weeks apart)
Change in Wechsler Picture Span performance
Change in Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Scale Picture Span performance
Time frame: Visit 1 and Visit 5 (approx. 3 weeks apart)
Change in Oral Word Reading Fluency performance
Change in Oral Word Reading Fluency performance
Time frame: Visit 1 and Visit 5 (approx. 3 weeks apart)
Change in Math Fluency performance
Change in Mathematics Fluency performance
Time frame: Visit 1 and Visit 5 (approx. 3 weeks apart)
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — There is no plan to share IPD with other researchers.
Started Nov 2022 (actual). Primary completion is estimated for May 2027, 54 months after the start.
Of 28 interventional studies with no phase under Fetal Alcohol Spectrum Disorders, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 43. This study's planned 54 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fetal Alcohol Spectrum Disorders →